Benzinga | Jun 15, 2021 08:19AM EDT

Raymond James Initiates Coverage On Myriad Genetics with Market Perform Rating

Raymond James analyst Andrew Cooper initiates coverage on Myriad Genetics (NASDAQ:MYGN) with a Market Perform rating.